HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul L Wood Selected Research

phosphatidal ethanolamines

11/2018Tear Film Amphiphilic and Anti-Inflammatory Lipids in Bovine Pink Eye.
10/2015Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer's disease subjects.
2/2015Dysfunctional plasmalogen dynamics in the plasma and platelets of patients with schizophrenia.
12/2011Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease.
11/2007Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul L Wood Research Topics

Disease

11Alzheimer Disease (Alzheimer's Disease)
01/2022 - 04/2002
9Cognitive Dysfunction
02/2022 - 12/2005
6Schizophrenia (Dementia Praecox)
10/2019 - 03/2005
5Dementia (Dementias)
01/2018 - 11/2007
4Neoplasms (Cancer)
11/2018 - 06/2010
4Neurodegenerative Diseases (Neurodegenerative Disease)
05/2007 - 04/2002
3Inflammation (Inflammations)
08/2022 - 03/2019
3Infections
01/2022 - 01/2018
3Multiple Sclerosis
01/2022 - 05/2007
3Parkinson Disease (Parkinson's Disease)
01/2022 - 05/2007
3Colorectal Neoplasms (Colorectal Cancer)
12/2018 - 02/2010
2Stroke (Strokes)
01/2022 - 04/2002
2Lewy Body Disease (Lewy Body Dementia)
01/2022 - 01/2018
2Asthma (Bronchial Asthma)
01/2021 - 03/2019
2Neuroinflammatory Diseases
01/2018 - 02/2012
2Disease Progression
01/2014 - 02/2012
2Pelizaeus-Merzbacher Disease
10/2011 - 06/2011
2Neuralgia (Stump Neuralgia)
07/2008 - 03/2005
1Atherosclerosis
08/2022
1Gaucher Disease (Gaucher's Disease)
01/2022
1Spinal Cord Injuries (Spinal Cord Injury)
01/2022
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2022
1Osteoarthritis
01/2021
1Conjunctivitis
11/2018
1Eye Infections
11/2018
1Bacterial Infections (Bacterial Infection)
11/2018
1Leptospirosis
01/2018
1Tuberculosis (Tuberculoses)
01/2018
1Malnutrition (Nutritional Deficiencies)
01/2018
1Proteostasis Deficiencies
01/2018
1Paratuberculosis (Johne's Disease)
01/2018
1Cerebral Cortical Thinning
06/2016
1Bipolar Disorder (Manic Depressive Psychosis)
08/2015
1Glioma (Gliomas)
06/2015
1Psychotic Disorders (Schizoaffective Disorder)
02/2015
1Amyloid Plaque
02/2012
1Pathologic Processes
02/2012

Drug/Important Bio-Agent (IBA)

18LipidsIBA
08/2022 - 06/2011
11Biomarkers (Surrogate Marker)IBA
03/2019 - 10/2009
9PlasmalogensIBA
10/2015 - 01/2010
6Fatty Acids (Saturated Fatty Acids)IBA
08/2022 - 10/2009
5phosphatidal ethanolaminesIBA
11/2018 - 11/2007
5DiglyceridesIBA
01/2018 - 01/2015
4Pharmaceutical PreparationsIBA
11/2011 - 12/2005
3SphingolipidsIBA
10/2019 - 01/2018
3Proteins (Proteins, Gene)FDA Link
01/2018 - 02/2012
3AldehydesIBA
02/2008 - 11/2006
2Biological ProductsIBA
02/2022 - 06/2016
2AcidsIBA
01/2022 - 12/2018
2OrnithineIBA
01/2022 - 12/2020
2N-(4-aminophenethyl)spiroperidol (NAPS)IBA
10/2019 - 01/2014
2Sulfoglycosphingolipids (Sulfatides)IBA
10/2019 - 08/2015
2Phosphatidic Acids (Phosphatidic Acid)IBA
11/2018 - 06/2015
2Glycerophospholipids (Phosphoglycerides)IBA
11/2018 - 01/2018
2Choline (Choline Chloride)IBA
01/2018 - 02/2015
2Amyloid (Amyloid Fibrils)IBA
06/2016 - 11/2007
2Docosahexaenoic AcidsIBA
06/2015 - 12/2011
2choline plasmalogensIBA
02/2015 - 11/2014
2Cholinergic Agents (Cholinergics)IBA
02/2012 - 11/2007
2Ether (Diethyl Ether)IBA
12/2011 - 10/2011
2PPI-1011IBA
12/2011 - 10/2011
2PolyaminesIBA
11/2011 - 05/2007
2Methionine (L-Methionine)FDA Link
07/2011 - 10/2009
2Phospholipids (Phosphatides)FDA LinkGeneric
01/2010 - 10/2009
2Glycine (Aminoacetic Acid)FDA LinkGeneric
07/2008 - 03/2005
1anandamide (arachidonylethanolamide)IBA
08/2022
1AmidesIBA
08/2022
1EndocannabinoidsIBA
08/2022
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2022
1Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
01/2022
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
12/2020
1Hydroxyl RadicalIBA
12/2020
1stearic acid (magnesium stearate)FDA LinkGeneric
12/2020
1isospaglumic acid (NAAGA)IBA
10/2019
1Excitatory Amino AcidsIBA
10/2019
1Surface-Active Agents (Surfactants)IBA
03/2019
1cyclic phosphatidic acid 16:0IBA
11/2018
1resolvin E2IBA
11/2018
1ProdrugsIBA
11/2018
1Phospholipases (Phospholipase)IBA
01/2018
1Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
01/2018
1VaccinesIBA
01/2018
1Phosphorylcholine (Phosphocholine)IBA
01/2018
1Phosphatidylcholines (Phosphatidylcholine)IBA
01/2018
1phosphatidylethanolamineIBA
10/2015
1MonoglyceridesIBA
10/2015
1Phosphatidylethanolamines (Cephalins)IBA
10/2015
1PhosphatidylserinesIBA
08/2015
1GlycosphingolipidsIBA
11/2014
1Ethanolamine (Colamine)IBA
01/2014
1nasIBA
01/2014
1ApolipoproteinsIBA
02/2012
1Ibuprofen (Motrin)FDA LinkGeneric
11/2011
1Membrane Transport Proteins (Biological Pump)IBA
11/2011
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
11/2011

Therapy/Procedure

5Therapeutics
01/2018 - 06/2006
1Meditation
08/2022
1Analgesia
08/2022
1Chemoprevention
11/2011